KRAS and neoplasm: Downstream of KRAS in ERK/MAPK signalling lies BRAF, a gene that in sporadic disease is mutated in ∼10% of CRC and is more highly associated with tumours showing microsatellite instability (MSI) (Bos et al, 1987; Jass, 2007).